ABION Inc.
KOSDAQ-listed biotech developing biomarker-driven targeted cancer therapies including lead candidate Vabametkib (ABN401).
Price
Change
Market cap
Business overview
Source: DART corporate disclosureFounded in 2007 and listed on KOSDAQ in 2021, ABION is a companion-diagnostics-based anticancer drug developer. Its pipeline includes Vabametkib (ABN401), a targeted therapy for non-small cell lung cancer, ABN501, an antibody platform targeting Claudin3, ABN202, an antibody-cytokine fusion protein platform, and ABN101, an interferon-beta based broad-spectrum antiviral therapeutic. It discovers biomarkers to use in patient selection, combination therapy design, and resistance-mechanism analysis, aiming to raise clinical success rates and commercial value.
Regulatory approvals
data.go.kr1 Orphan Drug designations · 2025 / 9 Korean MFDS device approvals · 2001–2015
- Orphan바바메킵2025-08-13Orphan Drug designation · in development20250046982
- MFDSSchirmer stripRevoked2015-04-20Product approval · Class 1서울 수신 15-790 호
- MFDSTelemetry system transmitter, analysisRevoked2004-07-09Product approval · Class 2제허 04-738 호
- MFDS의료용영상처리용장치소프트웨어Revoked2002-11-07Product approval · Class 2제허 02-867 호
- MFDS의료용영상처리용장치소프트웨어Revoked2002-07-02Product approval · Class 2제허 02-561 호
- MFDS의료용영상처리용장치소프트웨어Revoked2002-07-02Product approval · Class 2제허 02-562 호
- MFDS의료용영상처리용장치소프트웨어Revoked2002-07-02Product approval · Class 2제허 02-563 호
- MFDS의료용영상처리용장치소프트웨어Revoked2002-07-02Product approval · Class 2제허 02-564 호
- MFDS의료용영상처리용장치소프트웨어Revoked2002-06-08Product approval · Class 2제허 02-482 호
- MFDS의료용영상처리용장치소프트웨어Revoked2001-12-12Product approval · Class 2제허 01-728 호
Clinical trials
data.go.kr2 MFDS clinical trial authorisations · 2021–2022 (Phase 2 1 · Phase 1 1)
- Phase 2ABN401정(바바메킵), 레이저티닙2022-10-21
29 trial sites
- Phase 1ABN401정(바바메킵), 레이저티닙2021-11-24
3 trial sites
R&D and key agreements
Source: DART corporate disclosure바바메킵(Vabametkib, ABN401) · 비소세포폐암(NSCLC) · Biomarker-driven targeted therapy for non-small cell lung cancer
ABN501 · 고형암(Claudin3 발현) · Antibody platform targeting Claudin3
ABN202 · Antibody-cytokine fusion protein platform technology
ABN101 · 바이러스 감염 · Interferon-beta based broad-spectrum antiviral therapeutic
AI reads
MAA server logs · IP-verifiedSomeone asked an AI a question, and it fetched this page live to answer.
Collected for later use. Not a signal of interest.
- OpenAIOAI-SearchBot4
Measured since Aug 25, 2026 · 1 AI engines · last read Aug 26, 2026
User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS.
Companies approved for the same productsBiotech & Drug Discovery
Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.
Founded in 2002, INFINITT Healthcare provides PACS-centered medical imaging software and AI diagnostic aids across multiple clinical specialties.
Founded in 1985, BITComputer provides hospital information systems such as bitnixHIS and CLEMR, alongside digital healthcare and IT education businesses.
Founded in 1945, JW Pharmaceutical holds an original drug pipeline including Rivalo and Hemlibra, plus the IV nutrition product Winuf and OTC brand Hwakol.
KOSDAQ-listed X-ray imaging solution company with a full lineup of medical, dental, veterinary, and industrial X-ray detectors.
Founded in 1964 and KOSPI-listed in 1991, Shinhung manufactures and distributes dental equipment and materials.
Founded in 1992 and KOSDAQ-listed in 2006, VATECH manufactures dental digital X-ray and CT imaging diagnostic devices.
Vieworks, founded in 1999 and KOSDAQ-listed in 2009, develops X-ray detectors and industrial camera imaging solutions.
KOSDAQ-listed integrated security company behind the V3 antivirus and AhnLab TrusGuard and XDR solutions.
Organoid-based biotech founded 2018, KOSDAQ-listed 2025, developing the ATORM-C regenerative therapeutic and ODISEI evaluation solution.
Genomics and drug developer behind the osteoarthritis drug Acelex and the AI-driven healthcare platform Invites Loop.
EDGC, a Korea-US joint venture of Eone Medical Foundation and Diagnomics, offers the NIPT service NICE and liquid biopsy OncoCatch.
A diversified SK group company operating eco-friendly chemical materials alongside pharmaceutical products like Joins and vaccines through subsidiary SK Bioscience.
Sources and updates
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- AI visibility
- Measured 2026-08-13
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition